ScholarIQanswers from OpenAlex
Institute of Oncology Research
InstitutionResearch output, impact & collaborations
Institute of Oncology Research is a institution indexed in ScholarIQ from OpenAlex.
What is known about Institute of Oncology Research?
ScholarIQrecord summary
Institute of Oncology Research is a research organisation in Bellinzona, CH. OpenAlex records 3,555 works and 410,769 citations for it. 494 researchers list it as their most recent affiliation.
How many works does Institute of Oncology Research have?
ScholarIQindexed works
Institute of Oncology Research has 3,555 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Institute of Oncology Research have?
ScholarIQcitation count
Institute of Oncology Research has 410,769 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Institute of Oncology Research?
ScholarIQresearcher count
Institute of Oncology Research has 494 researchers in the ScholarIQ index.
What is the average h-index at Institute of Oncology Research?
ScholarIQavg h-index
Institute of Oncology Research has an average h-index of 74 in OpenAlex.
What is the ROR of Institute of Oncology Research?
ScholarIQror
The ROR for Institute of Oncology Research is on the source record.
What is the OpenAlex record for Institute of Oncology Research?
ScholarIQopenalex
The OpenAlex for Institute of Oncology Research is on the source record.
Who are the most-cited researchers behind Institute of Oncology Research?
ScholarIQtop researchers by citations
What are the most-cited papers on Institute of Oncology Research?
ScholarIQmost cited works
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant, Tjalling Bosse, Antonio González-Martı́n, Jonathan A. Ledermann, Christian Marth, Remi A. Nout, Denis Querleu, Mansoor Raza Mirza, Cristiana Sessa, Miguel Abal, Özden Altundağ, Frédéric Amant, Antoni Van Leeuwenhoek, Susana Banerjee, Tjalling Bosse, Antonio Casado, L Chiva de Agustín, David Cibula, Nicoletta Colombo, Carien L. Creutzberg, José María Del Campo, Günter Emons, Frédéric Goffin, Antonio González-Martı́n, Stefano Greggi, Christine Haie-Méder, Dionyssios Katsaros, Vesna Kesić, Christian Kurzeder, Sigurd Lax, Fabrice Lécuru, Jonathan A. Ledermann, Tally Levy, Domenica Lorusso, Johanna Mäenpää, Christian Marth, Xavier Matías‐Guiu, Philippe Morice, Hans W. Nijman, Remi A. Nout, Melanie Powell, Denis Querleu, Mansoor Raza Mirza, Nicholas Reed, Alexandros Rodolakis, Helga B. Salvesen, Jalid Sehouli, Cristiana Sessa, Alexandra Taylor, Anneke M. Westermann, Alain G. Zeimet
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Nicoletta Colombo, Cristiana Sessa, Andreas du Bois, Jonathan A. Ledermann, W. Glenn McCluggage, Iain A. McNeish, Philippe Morice, Sandro Pignata, Isabelle Ray‐Coquard, Ignace Vergote, Thaïs Baert, I. Belaroussi, A. Dashora, Siel Olbrecht, François Planchamp, Denis Querleu, Thaïs Baert, Susana Banerjee, I. Belaroussi, Paweł Blecharz, Ilan Bruchim, David Cibula, Nicoletta Colombo, Nicole Concin, Ben Davidson, A. Dashora, Mojgan Devouassoux‐Shisheboran, Andreas du Bois, Annamaria Ferrero, Rosalind Glasspool, Antonio González-Martı́n, Viola Heinzelmann‐Schwarz, Florence Joly, J.W. Kim, Frédéric Kridelka, Jonathan A. Ledermann, Domenica Lorusso, Sven� Mahner, W. Glenn McCluggage, Iain A. McNeish, Mikio Mikami, Mansoor Raza Mirza, Philippe Morice, Shibani Nicum, Siel Olbrecht, Dearbhaile M. O’Donnell, Patricia Pautier, François Planchamp, Sandro Pignata, Denis Querleu, Isabelle Ray‐Coquard, Alexandros Rodolakis, Jalid Sehouli, Fatih Selçukbırıcık, Cristiana Sessa, Nilanchali Singh, David S.P. Tan, D. Timmerman, Germana Tognon, Jacobus van der Velden, Ignace Vergote, Petronella O. Witteveen, Alain G. Zeimet
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Jonathan A. Ledermann, F. Raja, Christina Fotopoulou, Antonio González-Martı́n, Nicoletta Colombo, Cristiana Sessa
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant, Tjalling Bosse, Antonio González-Martı́n, Jonathan A. Ledermann, Christian Marth, Remi A. Nout, Denis Querleu, Mansoor Raza Mirza, Cristiana Sessa
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
Éric Pujade-Lauraine, Keiichi Fujiwara, Jonathan A. Ledermann, Amit M. Oza, Rebecca Kristeleit, Isabelle-Laure Ray-Coquard, Gary Richardson, Cristiana Sessa, Kan Yonemori, Susana Banerjee, Alexandra Léary, Anna V. Tinker, Kyung Hae Jung, Radosław Mądry, Sang‐Yoon Park, Charles Anderson, Fabian Zohren, Ross Stewart, Caimiao Wei, Samuel S. Dychter, Bradley J. Monk
How much of the research on Institute of Oncology Research is open access?
ScholarIQopen access share
86%OPEN ACCESS